FDA Planning To Solicit Information Aimed At Cutting Needlestick Risk
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to issue an advance notice of proposed rulemaking (ANPRM) to collect information on further steps to reduce the risk of needlestick injuries, the agency announced Sept 5. The advance notice will seek comments on whether FDA should develop a standard for devices that may cause sharps injury.